Amifostine (WR-2721) Shortens the Engraftment Period of 4-Hydroperoxycyclophosphamide-Purged Bone Marrow in Breast Cancer Patients Receiving High-Dose Chemotherapy With Autologous Bone Marrow Support
Titel:
Amifostine (WR-2721) Shortens the Engraftment Period of 4-Hydroperoxycyclophosphamide-Purged Bone Marrow in Breast Cancer Patients Receiving High-Dose Chemotherapy With Autologous Bone Marrow Support
Auteur:
Shpall, Elizabeth J. Stemmer, Salomon M. Hami, Lisa Franklin, Wilbur A. Shaw, Leslie Bonner, Heather S. Bearman, Scott I. Peters, William P. Bast Jr., Robert C. McCulloch, William Capizzi, Robert Mitchell, Edith Schein, Philip S. Jones, Roy B.